ScoreComparison
Why is Emergent BioSolutions, Inc. ?
1
Poor long term growth as Operating profit has grown by an annual rate -16.76% of over the last 5 years
2
Positive results in Jun 25
- OPERATING CASH FLOW(Y) Highest at USD 169 MM
- NET PROFIT(HY) Higher at USD 53.95 MM
- ROCE(HY) Highest at 30.24%
3
With ROE of -15.10%, it has a risky valuation with a 0.67 Price to Book Value
- Over the past year, while the stock has generated a return of 36.76%, its profits have fallen by -344%
4
Market Beating Performance
- The stock has generated a return of 36.76% in the last 1 year, much higher than market (S&P 500) returns of 14.11%
Real-Time Research ReportHow much should you hold?
- Overall Portfolio exposure to Emergent BioSolutions, Inc. should be less than 10%
- Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock
Is Emergent BioSolutions, Inc. for you?
High Risk, High Return
Absolute
Risk Adjusted
Volatility
Emergent BioSolutions, Inc.
40.73%
0.89
93.93%
S&P 500
16.12%
0.70
20.15%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
-9.96%
EBIT Growth (5y)
-15.29%
EBIT to Interest (avg)
4.18
Debt to EBITDA (avg)
4.15
Net Debt to Equity (avg)
0.93
Sales to Capital Employed (avg)
0.76
Tax Ratio
100.00%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
96.07%
ROCE (avg)
9.11%
ROE (avg)
7.50%
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
6
Industry P/E
Price to Book Value
0.76
EV to EBIT
7.39
EV to EBITDA
3.97
EV to Capital Employed
0.86
EV to Sales
1.09
PEG Ratio
0.04
Dividend Yield
NA
ROCE (Latest)
11.62%
ROE (Latest)
12.65%
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bullish
RSI
Bullish
No Signal
Bollinger Bands
Bearish
Bearish
Moving Averages
Mildly Bullish (Daily)
KST
Bearish
Mildly Bearish
Dow Theory
No Trend
Mildly Bearish
OBV
No Trend
Mildly Bullish
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend17What is working for the Company
ROCE(HY)
Highest at 13.92%
RAW MATERIAL COST(Y)
Fallen by -2.7% (YoY
DEBT-EQUITY RATIO
(HY)
Lowest at 72.41 %
OPERATING PROFIT(Q)
Highest at USD 100.6 MM
OPERATING PROFIT MARGIN(Q)
Highest at 43.53 %
NET PROFIT(Q)
At USD 51.47 MM has Grown at 44.85%
-9What is not working for the Company
NET SALES(HY)
At USD 372 MM has Grown at -32.18%
INVENTORY TURNOVER RATIO(HY)
Lowest at 1.25 times
Here's what is working for Emergent BioSolutions, Inc.
Operating Profit
Highest at USD 100.6 MM
in the last five periodsMOJO Watch
Near term Operating Profit trend is positive
Operating Profit (USD MM)
Operating Profit Margin
Highest at 43.53 %
in the last five periodsMOJO Watch
Company's profit margin has improved
Operating Profit to Sales
Net Profit
At USD 51.47 MM has Grown at 44.85%
over average net sales of the previous four periods of USD 35.53 MMMOJO Watch
Near term Net Profit trend is positive
Net Profit (USD MM)
Debt-Equity Ratio
Lowest at 72.41 %
in the last five Semi-Annual periodsMOJO Watch
The company has been reducing its borrowing as compared to equity capital
Debt-Equity Ratio
Raw Material Cost
Fallen by -2.7% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin
Raw Material Cost as a percentage of Sales
Here's what is not working for Emergent BioSolutions, Inc.
Net Sales
At USD 372 MM has Grown at -32.18%
Year on Year (YoY)MOJO Watch
Near term sales trend is very negative
Net Sales (USD MM)
Inventory Turnover Ratio
Lowest at 1.25 times
in the last five Semi-Annual periodsMOJO Watch
Company's pace of selling inventory has slowed
Inventory Turnover Ratio
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
